Drug-Device Combination Products Market, By Product Type (Drug Eluting Stents (Coronary stent, Peripheral Vascular stents), Infusion pumps (Implantable, Ambulatory), Photosensitizers, Orthopedic combination products (Bone graft imlants + antibiotic loaded

Drug-Device Combination Products Market, By Product Type (Drug Eluting Stents (Coronary stent, Peripheral Vascular stents), Infusion pumps (Implantable, Ambulatory), Photosensitizers, Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements), Wound care combination products, Inhalers (Nebulizers, MDI, DPI), Transdermal patches, Others( Intraocular implants, drug eluting beads)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Drug device combination products consists of drugs administered or delivered through a specialized devices to the patients. Examples of such products include prefilled syringes, infusion pumps, drug coated devices such as stents, and others. Manufacturers such as Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, and others offer drug device combination products in the market.

Restraints of the Global Drug-Device Combination Products Market

Major factors hampering the growth of the drug-device combination products market during the forecast period constitutes of presence of stringent and non-specific regulatory pathway and risks associated with infections.

Key features of the study:

This report provides in-depth analysis of the global drug-device combination products market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global drug-device combination products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, Medtronic plc, Allergan, Inc., Alcon, Inc., Arrow International, Inc., Bausch & Lomb, Inc., Boston Scientific Corporation, ALK, SINOMED, Kaléo, Haselmeier, Flowonix Medical, Inc., CareFusion Corporation, and Covidien PLC

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global drug-device combination products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Drug-Device Combination Products Market, By Product Type:

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads)

Global Drug-Device Combination Products Market, By Geography:

North America

By Product Type

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads

By Country:

U.S.

Canada

Europe

By Product Type

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Product Type

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type

Drug Eluting Stents

Coronary stent

Peripheral Vascular stents

Infusion pumps

Implantable

Ambulatory

Photosensitizers

Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)

Wound care combination products

Inhalers

Nebulizers

MDI

DPI

Transdermal patches

Others( Intraocular implants, drug eluting beads

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Teva Pharmaceutical Industries Ltd.*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Becton, Dickinson and Company

Integer Holdings Corporation

Abbott Laboratories

Medtronic plc

Allergan, Inc.

Alcon, Inc.

Arrow International, Inc.

Bausch & Lomb, Inc.

Boston Scientific Corporation

Other Major Players

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario
4. Global Drug-Device Combination Products Market, By Product Type, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Drug Eluting Stents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Coronary stent
Peripheral Vascular stents
Infusion pumps
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Implantable
Ambulatory
Photosensitizers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Wound care combination products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Inhalers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Nebulizers
MDI
DPI
Transdermal patches
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Others( Intraocular implants, drug eluting beads)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
5. Global Drug-Device Combination Products Market, By Regions, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
6. Competitive Landscape
Company Profiles
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Becton, Dickinson and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Integer Holdings Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Medtronic plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Allergan, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Alcon, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Arrow International, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bausch & Lomb, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Boston Scientific Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Other Major Players
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
7. Section
References
Research Methodology
About us and Sales Contact
*Browse 35 market data tables and 26 figures on “Drug-Device Combination Products Market – Global forecast to 2027.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook